Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New version of the intra-DRG list published in France

30 Aug 2021

Certain medical devices are financed within the DRG tariff but require explicit review of clinical evidence by the National Committee for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) to ensure that they are safe and effective. This mechanism is called “intra-DRG” (intra-GHS) coverage. The mechanism is applicable to particularly invasive devices. Only devices listed in the intra-GHS list can be purchased by hospitals.

On August 5, 2021, the new intra-DRG list was published. However, no major changes were introduced in this version compared to the version of November 2020. No new devices were added to the list. More changes are expected at the end of September 2021.

The full details in French can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).